Neutropenia management in patients receiving myelosuppressive polychemotherapy for early breast cancer in Belgium: BRONS study results

Catala, Gaëtan; Mebis, Jeroen; Jérusalem, Guy; Verhoeven, Didier; Awada, Ahmad; Bols, Alain; Somers, Luc; Van den broeck, Anke; P. Duhoux, François; Machiels, Jean‐Pascal

doi:10.1080/17843286.2018.1563735

Public

Neutropenia management in patients receiving myelosuppressive polychemotherapy for early breast cancer in Belgium: BRONS study results

Published in Acta Clinica Belgica • Jan 4, 2019

Authors:

Gaëtan Catala

Jeroen Mebis

Guy Jérusalem

Abstract

Background: Chemotherapy plays an important role in the treatment of early breast cancer (EBC). Granulocyte-colony stimulating factors (G-CSF) can reduce the risk of febrile neutropenia as primary prophylaxis (PP) or secondary prophylaxis (SP). The BRONS study investigated the incidence of serious n...

Subject

Medicine

Neutropenia

Febrile neutropenia

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!